Back
Inhibrx Vs. Silk Road Medical Industry Stock Comparison
Sell
22
INBX
Inhibrx
Last Price:
19.33
Seasonality Move:
-22.08%
Sell
36
SILK
Silk Road Medical
Last Price:
38.04
Seasonality Move:
21.83%
Sell
22
Inhibrx (INBX)
is a Sell
Is Inhibrx a Buy, Sell or Hold?
- The current Inhibrx [INBX] share price is $19.30. The Score for INBX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- INBX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Silk Road Medical (SILK)
is a Sell
Is Silk Road Medical a Buy, Sell or Hold?
- The current Silk Road Medical [SILK] share price is $38.09. The Score for SILK is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SILK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SILK Stock Price Chart
What is Silk Road Medical's stock price today?
-
The Silk Road Medical share price today is $38.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SILK is experiencing slight buying pressure.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 33.13 | Sell |
| Chaikin Money Flow: | -239894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.34 - 24.14) | Sell |
| Bollinger Bands (100): | (22.54 - 29.36) | Sell |
SILK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.04 | Sell |
| Relative Strength Index (14 RSI): | 27.35 | Sell |
| Chaikin Money Flow: | 130527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.08 - 51.1) | Sell |
| Bollinger Bands (100): | (45.57 - 54.85) | Sell |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.05 | Sell |
| 20-day SMA: | 22.49 | Sell |
| 50-day SMA: | 23.61 | Sell |
| 200-day SMA: | 22.59 | Sell |
| 8-day EMA: | 20.98 | Sell |
| 20-day EMA: | 22.07 | Sell |
| 50-day EMA: | 23.39 | Sell |
| 200-day EMA: | 23.95 | Sell |
SILK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41 | Sell |
| 20-day SMA: | 44.38 | Sell |
| 50-day SMA: | 49.66 | Sell |
| 200-day SMA: | 46.07 | Sell |
| 8-day EMA: | 40.75 | Sell |
| 20-day EMA: | 43.79 | Sell |
| 50-day EMA: | 47.42 | Sell |
| 200-day EMA: | 46.89 | Sell |
Inhibrx Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.07 per share.
Silk Road Medical Earnings Growth & SILK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.08 per share, and an increase next year of $0.19 per share.
Inhibrx Technical Analysis
| Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Silk Road Medical Technical Analysis
| Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||